URZ3 Energy Welcomes Dr. Ivy Estabrooke to the Advisory Board

Core Insights - URZ3 Energy Corp. has appointed Dr. Ivy V. Estabrooke to its Advisory Board, enhancing its strategic planning capabilities in the uranium sector [1][2] Company Overview - URZ3 Energy Corp. is focused on the acquisition and exploration of uranium properties in North America, aiming to meet the increasing demand for uranium as a clean energy resource [7] Advisory Board Appointment - Dr. Estabrooke brings a unique combination of national security experience, advanced technology leadership, and direct uranium-sector board experience, which aligns with URZ3's U.S.-focused uranium strategy [2] - The company has granted Dr. Estabrooke 100,000 incentive stock options at a price of $0.335 per common share, expiring on November 28, 2030, subject to regulatory acceptance [6] Dr. Ivy V. Estabrooke's Background - Dr. Estabrooke has extensive experience in technology development and deployment in national security and healthcare, and has served on various boards, including Rare Earths Americas and Energy Fuels Inc. [3][4] - She holds a PhD in neuroscience from Georgetown University, a master's in national resource management from the National Defense University, and a bachelor's in biological sciences from Smith College [5]